Stocknews
FTSE Bursa Malaysia KLCI (^KLSE) 1,646.53 14.83 (0.90%)
updated at: Wed, 09 Dec 2020, 05:25PM MYT

Duopharma Biotech may rebound further, says RHB Retail Research

DPHARMA
DPHARMA
Original Source From TheEdge Publish at Fri, 24 Apr 2020, 08:14AM

KUALA LUMPUR (April 24): RHB Retail Research said Duopharma Biotech Bhd may rebound further after it tested the RM1.44 support in recent sessions.

In a trading stocks note today, the research house said as the stock marked a higher close vis-à-vis the previous sessions since April 22, this indicates a positive sign.

“An upbeat bias may emerge above the RM1.51 level, with an exit set below the RM1.44 mark.

“Towards the upside, the immediate resistance is at the RM1.67 level, followed by the RM1.78 threshold,” it said.

Top Participation View More
updated at: Fri, 29 May 2020 MYT
Participation (%)
Bought (MYR)
Sold (MYR)
Net
Foreign
( 24,36 % )
2.31 B 2.23 B 77.37 M
Local Institution
( 39,38 % )
3.66 B 3.67 B 0.00 B
Local Retail
( 36,26 % )
3.34 B 3.41 B -0.07 B